The research development of inflammatory signal pathway of atherosclerosis

Chinese Pharmacological Bulletin

Volumn 25, Issue 7, 2009, Pages

  Li, Yu Jie ^a   Yang, Qing ^a   Weng, Xiao Gang ^a   Wang, Yi Wei ^a   Zhu, Xiao Xin ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

Atherosclerosis; Inflammation; Signal pathway

Indexed keywords

ANTIINFLAMMATORY AGENT;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; DRUG RESEARCH; HUMAN; INFLAMMATION; RISK FACTOR; SIGNAL TRANSDUCTION;

EID: 70350331690     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Li Y J, Yang Q, Zhu X X. TCM anti-inflammation: An effective approach for treating atherosclerosis[J]. World Sci Technol/Mod Tradit Chin Med Mat Med, 22007,9(2):6.
2. Xie L X, Fang F, Li H, Fang Y X. Immunomodulation and vaccine development of atherosclerosis[J]. Chin Pharmacol Bull,2007,23(3):285-288
3. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s[J]. Nature,1993,362:801.
4. Ross R. Atherosclerosis an inflammatory disease[J]. N Engl J Med,1999,340(2):115.
5. Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime [J]. Nat Med,2002,8: 1211.
6. Zhao L, Moos M P, Grabner R, et al. The 5-lipoxygenase pathway promotes pathogenesis of hyper-lipidemia-dependent aortic aneurysm[J]. Nat Med,2004,10:966-973
7. Zhou Y J, Wang J H, Li L, et al. Expanding expression of the 5-lipoxygenase/leukotriene B4 pathway in atherosclerotic lesions of diabetic patients promotes plaque instability[J]. Biochem Biophys Res Commun,2007,363:30-36
8. Heller E A, Liu E, Tager A M, et al. Inhibition of atherogenesis in BLT1-deficient mice reveals a role for LTB4 and BLT1 in smooth muscle cell recruitment[J]. Circulation,2005,112:578-586
9. Wickelgren I. Heart disease. Gene suggests asthma drugs may ease cardiovascular inflammation[J]. Science,2004,303:941.
10. Kota R S, Ramana C V, Tenorio F A, et al. Differential effects of lipoprotein lipase on tumor necrosis factor-alpha and interferon-gamma-mediated gene expression in human endothelial cells[J]. J Biol Chem,2005,280:31076-31084
11. Von Eckardstein A, Hersberger M, Rohrer L. Current understanding of the metabolism and biological actions of HDL[J]. Curr Opin Clin Nutr Metab Care,2005,8:147-152
12. Botham K M, Bravo E, Elliott J, et al. Direct interaction of dietary lipids carried in chylomicron remnants with cells of the artery wall: implications for atherosclerosis development[J]. Curr Pharm Des,2005,11:3681- 3695
13. Takahashi Y, Fujioka Y, Takahashi T, et al. Chylomicron remnants regulate early growth response factor-1 in vascular smooth muscle cells[J]. Life Sci,2005,77:670-682
14. McEwen J E, Zimniak P, Mehta J L, et al. Molecular pathology of aging and its implications for senescent coronary atherosclerosis [J]. Curr Opin Cardiol,2005,20:399-406.
15. Lupo G, Nicotra A, Giurdanella G, et al. Activation of phospholipase A(2) and MAP kinases by oxidized low-density lipoproteins in immortalized GP8.39 endothelial cells[J]. Biochim Biophys Acta,2005,1735:135-150
16. Mehta J L, Sanada N, Hu C P, et al. Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet [J]. Circ Res,2007,100:1634-1642
17. Birukova A A, Chatchavalvanich S, Oskolkova O, et al. Signaling pathways involved in OxPAPC-induced pulmonary endothelial barrier protection[J]. Microvasc Res,2007,73:173-181
18. Yamawaki H, Pan S, Lee R T, et al. Fluid shear stress inhibits vascular inflammation by decreasing thioredoxin-interacting protein in endothelial cells[J]. J Clin Invest,2005,115:733-738
19. Cheng Z J, Vapaatalo H, Mervaala E. Angiotensin II and vascular inflammation[J]. Med Sci Monit,2005,11:RA194-205.
20. Guest T M, Vlastos G, Alameddine F M, et al. Mechanoregulation of monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cells[J]. Antioxid Redox Signal,2006,8:1461-1471
21. Kamimura M, Viedt C, Dalpke A, et al. Interleukin-10 suppresses tissue factor expression in lipopolysaccharide-stimulated macrophages via inhibition of Egr-1 and a serum response element/MEK-ERK1/2 pathway[J]. Circ Res,2005,97:305-313
22. 2+ signals and nitric oxide synthesis through epidermal growth factor receptor kinase and calmodulin kinase II [J]. J Biol Chem,2005,280:35999-36006
23. Venugopal S K, Devaraj S, Jialal I. Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role [J]. Curr Opin Nephrol Hypertens,2005,14:33-37
24. M-CSF RAW 264.7 MMP-9 [J]. 2006,22 (8):947-951 [24] Wang C, Xu C X, Peng C Y, et al. Wpiegulation of macrophage colonystimu-lating factor on protease secretion in RAW 264. 7 cell and its possible mechanism[J]. Chin Pharmacol Bull,2006,22(8):947-951
25. Krull M, Kramp J, Petrov T, et al. Differences in cell activation by Chlamydophila pneumoniae and Chlamydia trachomatis infection in human endothelial cells[J]. Infect Immun,2004,72:6615-6621
26. Ding M, Ye T X, Zhao G R, et al. Aqueous extract of Salvia miltiorrhiza attenuates increased endothelial permeability induced by tumor necrosis factor-alpha [J]. Int Immunopharmacol,2005,5:1641-1651
27. Lin S J, Lee I T, Chen Y H, et al. Salvianolic acid B attenuates MMP-2 and MMP-9 expression in vivo in apolipoprotein-E-deficient mouse aorta and in vitro in LPS-treated human aortic smooth muscle cells[J]. J Cell Biochem,2007,100:372-384
28. Chen Y L, Hu C S, Lin F Y, et al. Salvianolic acid B attenuates cyclooxygenase-2 expression in vitro in LPS-treated human aortic smooth muscle cells and in vivo in the apolipoprotein-E-deficient mouse aorta[J]. J Cell Biochem,2006,98:618-631
29. Lin S J, Lee I T, Chen Y H, et al. Salvianolic acid B attenuates MMP-2 and MMP-9 expression in vivo in apolipoprotein-E-deficient mouse aorta and in vitro in LPS-treated human aortic smooth muscle cells[J]. J Cell Biochem,2007,100:372-384
30. Ding M. Regulation of salvia miltiorrhiza on signal transduction of endothelial cells[D]. Tianjin University,2005.
31. Chen S C, Chang Y L, Wang D L, et al. Herbal remedy magnolol suppresses IL-6-induced STAT3 activation and gene expression in endothelial cells[J]. Br J Pharmacol,2006,148:226-232
32. Lin R, Liu J, Peng N, et al. Lovastatin reduces nuclear factor kappaB activation induced by C-reactive protein in human vascular endothelial cells[J]. Biol Pharm Bull,2005,28:1630-1634
33. Wang H R, Li J J, Huang C X, et al. Fluvastatin inhibits the expression of tumor necrosis factor-alpha and activation of nuclear factor-kappaB in human endothelial cells stimulated by C-reactive protein[J]. Clin Chim Acta,2005,353:53-60.